Stephens Inc’s Amedisys AMED Stock Holding History

Stephens Inc’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,874	Closed	-$246K	–	1149
2019 Q3	$246K	Sell	1,874 -15	-0.8%	-$1.95K	0.01%	982
2019 Q2	$229K	Buy	+1,889	New	+$224K	0.01%	1019

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Stephens Inc's AMED Position: Q4 2019 in Review

Stephens Inc sold out of Amedisys (AMED) in Q4 2019, closing a stake of 1,874 shares — an estimated $246K sold.

Stephens Inc first reported a position in AMED in Q2 2019 and held it in 2 quarters. The position peaked at $246K in Q3 2019. 325 funds tracked by Wall St. Rank hold AMED as of Q4 2019.

Stephens Inc reported no remaining Amedisys position as of Q4 2019 after selling out during the quarter.
Stephens Inc sold 1,874 Amedisys shares in Q4 2019, an estimated $246K.
Stephens Inc first reported a position in Amedisys in Q2 2019 and held it in 2 quarters.
Stephens Inc's Amedisys position peaked at $246K in Q3 2019.
325 funds tracked by Wall St. Rank held Amedisys as of Q4 2019.

Based on Stephens Inc's 13F filing for Q4 2019, filed 14 Feb 2020.